ASO Visual Abstract: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma

Ann Surg Oncol. 2025 Dec;32(13):9685-9686. doi: 10.1245/s10434-025-18507-y.
No abstract available